Lanzatech co-founder: we are missing out on the synthetic biology revolution

Lanzatech co-founder: we are missing out on the synthetic biology revolution
Dr Sean Simpson. (Image: Getty)
Peter Griffin
The third New Zealand-founded company in as many years is set to list on the Nasdaq.LanzaTech’s merger with “blank cheque” Nasdaq-listed company AMCI Acquisition Corp II sees it follow in the footsteps of Rocket Lab and footwear maker All Birds in taking the special purpose acquisition company (SPAC) route to become a publicly traded company.The deal, which values the merged company at around US$1.8 billion (NZ$2.8b), was cleared by shareholders on Tuesday. It confirms the Illinois-based LanzaTech’s status as our mo...

More Opinion

Cleantech: Burst bubble or our biggest opportunity?
Opinion

Peter Griffin: Cleantech: Burst bubble or our biggest opportunity?

A thriving cleantech sector could be NZ’s ticket to a sustainable, high-value economy.

Peter Griffin 02 Jul 2025
Why luxury needs a wake-up call
Opinion Fashion

Eden Bradfield: Why luxury needs a wake-up call

The focus should be on selling consumers a lifestyle, not just status symbols. 

Eden Bradfield 01 Jul 2025
Facebook is no place for risky financial investment offers
Opinion

Maria Slade: Facebook is no place for risky financial investment offers

Misleading ads continue to be thrust in the faces of Mum and Dad investors.

Maria Slade 30 Jun 2025